Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John E Le Lay

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Journal of Clinical Investigation|April 14, 2015
TALE-mediated epigenetic suppression of CDKN2A increases replication in human fibroblastsDiana L Bernstein, John E Le Lay, Elena G Ruano, et al.
Epigenetics & Chromatin|August 4, 2015
The BisPCR(2) method for targeted bisulfite sequencingDiana L Bernstein, Vasumathi Kameswaran, John E Le Lay, et al.
Science Translational Medicine|April 22, 2021
Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trialJohn E Le Lay, Qun Du, Minal B Mehta, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Journal of Clinical Investigation|April 14, 2015
TALE-mediated epigenetic suppression of CDKN2A increases replication in human fibroblastsDiana L Bernstein, John E Le Lay, Elena G Ruano, et al.
Epigenetics & Chromatin|August 4, 2015
The BisPCR(2) method for targeted bisulfite sequencingDiana L Bernstein, Vasumathi Kameswaran, John E Le Lay, et al.
Science Translational Medicine|April 22, 2021
Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trialJohn E Le Lay, Qun Du, Minal B Mehta, et al.
Pageof 1